Universitätsklinikum Carl Gustav Carus an der TU

Dresden 1307

1 studies enrolling now · 3 studies all time

What they study most

Metastatic HER2-positive Breast Cancer, Perennial Allergic Rhinitis (PAR), Plaque Psoriasis

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) — Running, not enrolling
• A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis — Completed